SARS-CoV-2, Virology and Pathogenicity and phytomedicinal immunomodulators to curb covid-19 pandemic

被引:0
|
作者
Kumar, Sanjeev [1 ]
机构
[1] Univ Petr & Energy Studies, Dept Chem, Appl Sci Cluster, Dehra Dun, India
关键词
Covid-19; SARS Virus; Virology; plants; phytochemical; GINGER ZINGIBER-OFFICINALE; MOLECULAR DOCKING; MEDICINAL-PLANTS; VARIETIES; SARS-COV; CORONAVIRUS; VIRUS; INHIBITION; EXTRACT; IDENTIFICATION;
D O I
10.47750/pnr.2022.13.S06.115
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The new coronavirus, COVID-19 has sent the world into a medical and economic crisis and if not contained can cause unprecedented damage to the human population.COVID-19 is a new pathogen and a new coronavirus that poses a global threat to healthcare system worldwide and has already devoured many lives in different parts of the world. Till date, there is no specific vaccine or effective antiviral therapy against COVID-19 disease. The only way to prevent oneself is to maintain social distancing, maintain proper hygiene and simultaneously enhance the individual's immune response by incorporating immune boosters in daily diet, as health supplements and prophylaxis. Phytotherapy (herbalism) means usage of plants or herbs as medication to treat or prevent diseases and has a lot of potential. This phytomedicinal therapeutic approach proves to be cheaper and safer alternative and reduce the incidence of drug resistance and may modulate the immune system in preventing viral diseases. This traditional therapy has less side effects and bestow a general good health. It may suppress viral replication and reduce the clinical signs of viral diseases and can be promoted as immunomodulator. COVID 19 has been shown to engage the host cell ACE2 through its spike protein receptor binding domain (RBD) and natural phytochemical from plants have distinct effects on viral RBD and host ACE2 receptor complex. The present paper aims to present a comprehensive study of certain medicinal herbs to increase the immune potential and a promising option in the fore-front in healing COVID-19 ailments, concurrent with ICMR prescribed allopathic treatments.
引用
收藏
页码:844 / 859
页数:16
相关论文
共 50 条
  • [41] Lessons Learned during the Coronavirus – Covid-19 (SARS-CoV-2) Pandemic
    Bruzzese, Stacey L.
    [J]. Journal of Validation Technology, 2020, 26 (02)
  • [42] The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India
    Sylaja, P. N.
    Srivastava, M. V. Padma
    Shah, Sudhir
    Bhatia, Rohit
    Khurana, Dheeraj
    Sharma, Arvind
    Pandian, Jeyaraj D.
    Kalia, Kiran
    Sarmah, Deepaneeta
    Nair, Sruthi S.
    Yavagal, Dileep R.
    Bhattacharya, Pallab
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1473 (01) : 3 - 10
  • [43] The COVID-19 Pandemic Period, SARS-CoV-2 Infection, and Perinatal Health
    Jung, Shelley
    Liu, Emily F.
    Goin, Dana E.
    Rudolph, Kara E.
    Mujahid, Mahasin S.
    Dow, William H.
    Ahern, Jennifer
    [J]. JAMA NETWORK OPEN, 2024, 7 (05)
  • [44] The Contribution of SARS-CoV-2 Genomics to the Handling of the COVID-19 Pandemic in Portugal
    Gomes, Joao Paulo
    [J]. ACTA MEDICA PORTUGUESA, 2021, 34 (7-8) : 493 - 494
  • [45] B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020
    Hurwitz, Julia L.
    [J]. VIRAL IMMUNOLOGY, 2020, 33 (04) : 251 - 252
  • [46] COVID-19 (SARS-CoV-2) pandemic: fears, facts and preventive measures
    Ayenigbara, Israel Oluwasegun
    Adeleke, Olasunkanmi Rowland
    Ayenigbara, George Omoniyi
    Adegboro, Joseph Sunday
    Olofintuyi, Oluwaseyi Oye
    [J]. GERMS, 2020, 10 (03): : 218 - 228
  • [47] COVID-19: ICU delirium management during SARS-CoV-2 pandemic
    Katarzyna Kotfis
    Shawniqua Williams Roberson
    Jo Ellen Wilson
    Wojciech Dabrowski
    Brenda T. Pun
    E. Wesley Ely
    [J]. Critical Care, 24
  • [48] Africa's contribution to the science of the COVID-19/SARS-CoV-2 pandemic
    Kana, Musa Abubakar
    LaPorte, Ronald
    Jaye, Assan
    [J]. BMJ GLOBAL HEALTH, 2021, 6 (02):
  • [49] An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
    Pascual-Iglesias, Alejandro
    Canton, Javier
    Ortega-Prieto, Ana Maria
    Jimenez-Guardeno, Jose M.
    Regla-Nava, Jose Angel
    [J]. PATHOGENS, 2021, 10 (08):
  • [50] To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
    Spinelli, Francesca Romana
    Ceccarelli, Fulvia
    Di Franco, Manuela
    Conti, Fabrizio
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (05) : 666 - +